US6096879A
(en)
|
1978-12-18 |
2000-08-01 |
Institut Pasteur |
Nucleotide sequence comprising the genome of hepatitis B virus, nucleotide sequence coding the surface antigen of the hepatitis B virus, vectors containing the nucleotide sequences, process for the preparation thereof, and antigen obtained thereby
|
FR2480779B2
(fr)
|
1979-08-30 |
1986-07-18 |
Anvar |
Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
|
US6297355B1
(en)
|
1978-12-22 |
2001-10-02 |
Biogen, Inc. |
Polypeptides displaying HBV antigenicity or hbv antigen specificity
|
US5196194A
(en)
|
1979-05-24 |
1993-03-23 |
The Regents Of The University Of California |
Vaccines containing Hepatitis B S-protein
|
IL86833A0
(en)
|
1987-06-22 |
1988-11-30 |
Medico Labs |
Peptide containing immunogenic particles
|
US6297048B1
(en)
|
1992-02-04 |
2001-10-02 |
Chiron Corporation |
Hepatitis therapeutics
|
US6174666B1
(en)
|
1992-03-27 |
2001-01-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of eliminating inhibitory/instability regions from mRNA
|
US5595739A
(en)
|
1993-05-07 |
1997-01-21 |
Abbott Laboratories |
Hepatitis B virus mutants, reagents and methods for detection
|
GB9401987D0
(en)
|
1994-02-02 |
1994-03-30 |
Imperial College |
Modified nucleic acid
|
US7732423B2
(en)
|
1994-04-27 |
2010-06-08 |
Institut Pasteur |
Nucleotide vector, composition containing such vector, and vaccine for immunization against hepatitis
|
WO1996012027A1
(en)
|
1994-10-18 |
1996-04-25 |
Scottish Crop Research Institute |
Method of producing a chimeric protein
|
AU699398B2
(en)
|
1995-06-20 |
1998-12-03 |
General Hospital Corporation, The |
Inhibition of hepatitis B replication
|
ZA973367B
(en)
|
1996-04-19 |
1997-11-18 |
Innogenetics Nv |
Method for typing and detecting HBV.
|
AU4248297A
(en)
|
1996-09-03 |
1998-03-26 |
General Hospital Corporation, The |
Inhibition of viral replication
|
EP0919568A1
(en)
|
1997-12-01 |
1999-06-02 |
Sorin Diagnostics S.r.l. |
Escape mutant of the surface antigen of hepatitis B virus
|
FR2775435B1
(fr)
|
1998-02-27 |
2000-05-26 |
Bioalliance Pharma |
Nanoparticules comprenant au moins un polymere et au moins un compose apte a complexer un ou plusieurs principes actifs
|
WO1999066047A1
(en)
|
1998-06-19 |
1999-12-23 |
Government Of The Republic Of Singapore |
A vaccine-induced hepatitis b viral strain and uses thereof
|
CN1322251A
(zh)
|
1998-06-19 |
2001-11-14 |
新加坡共和国政府 |
一株突变的人乙型肝炎病毒株及其应用
|
US6787142B2
(en)
|
2001-04-30 |
2004-09-07 |
Government Of Republic Of Singapore |
Mutant human hepatitis B viral strain and uses thereof
|
BR9912070A
(pt)
|
1998-07-13 |
2001-04-10 |
Expression Genetics Inc |
Análogo de poliéster de poli-l-lisina como um solúvel, veìculo de distribuição de gene biodegradável
|
US7067247B2
(en)
|
2000-03-31 |
2006-06-27 |
Ortho-Clinical Diagnostics, Inc. |
Hepatitis B virus surface protein
|
AU6616301A
(en)
|
2000-06-22 |
2002-01-02 |
Celltech Pharmaceuticals Ltd |
Modification of hepatitis b core antigen
|
US7202354B2
(en)
|
2001-03-30 |
2007-04-10 |
Abbott Laboratories |
Hepatitis B virus surface antigen mutant and methods of detection thereof
|
EP1526840B1
(en)
|
2002-07-29 |
2008-09-17 |
NanoDel Technologies GmbH |
Nanoparticles for dna administration to a target organ
|
KR100991679B1
(ko)
|
2002-12-10 |
2010-11-04 |
셀덱스 테라퓨틱스 리미티드 |
안정화 면역원성 HBc 키메라 입자
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
CA3028774A1
(en)
*
|
2004-01-23 |
2005-08-04 |
Msd Italia S.R.L. |
Chimpanzee adenovirus vaccine carriers
|
EP3943494A1
(en)
|
2004-05-13 |
2022-01-26 |
Icos Corporation |
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
|
US7404969B2
(en)
|
2005-02-14 |
2008-07-29 |
Sirna Therapeutics, Inc. |
Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
|
TWI382019B
(zh)
|
2005-08-19 |
2013-01-11 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之胺基二氮雜呯
|
TW201402124A
(zh)
|
2005-08-19 |
2014-01-16 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯
|
EP1783228A1
(en)
|
2005-11-08 |
2007-05-09 |
ETH Zürich |
Recombinant expression of multiprotein complexes using polygenes
|
SI2038290T1
(sl)
|
2006-07-07 |
2014-01-31 |
Gilead Sciences, Inc. |
Modulatorji Tollu podobnega receptorja 7
|
EP2057268B1
(en)
|
2006-08-14 |
2014-08-13 |
Postech Foundation |
A dna vaccine for curing chronic hepatitis b and a method of preparing same
|
KR100836745B1
(ko)
|
2007-01-31 |
2008-06-10 |
(주)두비엘 |
Hbv 백신 및 그의 제조 방법
|
EP2170888B1
(en)
|
2007-06-29 |
2015-04-22 |
Gilead Sciences, Inc. |
Purine derivatives and their use as modulators of toll-like receptor 7
|
US8138318B2
(en)
|
2007-09-13 |
2012-03-20 |
Abbott Laboratories |
Hepatitis B pre-S2 nucleic acid
|
US8003621B2
(en)
|
2007-09-14 |
2011-08-23 |
Nitto Denko Corporation |
Drug carriers
|
DE102007062962A1
(de)
|
2007-12-21 |
2009-06-25 |
Siemens Healthcare Diagnostics Products Gmbh |
Neue Oberflächen-Protein-Mutante des Hepatitis B Virus HBV surface Antigen (HBsAg)
|
PL2604695T3
(pl)
|
2007-12-27 |
2023-04-11 |
Universität Zürich |
Cząstka arenawirusa z defektem replikacji
|
SI2824100T1
(en)
|
2008-07-08 |
2018-06-29 |
Incyte Holdings Corporation |
1,2,5-oxadiazoles as inhibitors of indolamine 2,3-dioxygenase
|
PL2313111T3
(pl)
|
2008-08-01 |
2014-08-29 |
Ventirx Pharmaceuticals Inc |
Preparaty agonistów receptora Toll-podobnego i ich zastosowanie
|
PL2364314T3
(pl)
|
2008-12-09 |
2014-08-29 |
Gilead Sciences Inc |
Modulatory receptorów Toll-podobnych
|
WO2010120874A2
(en)
|
2009-04-14 |
2010-10-21 |
Chimeros, Inc. |
Chimeric therapeutics, compositions, and methods for using same
|
KR20120104140A
(ko)
*
|
2009-07-02 |
2012-09-20 |
메르츠 파마 게엠베하 운트 코. 카가아 |
생물학적 활성이 감소된 신경독
|
MX2012001592A
(es)
*
|
2009-08-07 |
2012-05-22 |
Transgene Sa |
Composicion para el tratamiento de la infección del virus de la hepatitis b.
|
US10076570B2
(en)
*
|
2009-08-07 |
2018-09-18 |
Transgene S.A. |
Composition for treating HBV infection
|
RU2580320C2
(ru)
|
2009-08-18 |
2016-04-10 |
Вентиркс Фармасьютикалз, Инк. |
Замещенные бензоазепины в качестве модуляторов toll-подобного рецептора
|
DK2467377T3
(en)
|
2009-08-18 |
2017-04-03 |
Ventirx Pharmaceuticals Inc |
SUBSTITUTED BENZOAZEPINS AS MODULATORS OF TOLL-LIKE RECEPTORS
|
NO2491035T3
(es)
|
2009-10-22 |
2018-01-27 |
|
|
JP2012503494A
(ja)
|
2009-11-06 |
2012-02-09 |
チュン−アン ユニバーシティ インダストリー−アカデミー コーオペレイション ファンデイション |
ナノ粒子を含む遺伝子運搬体
|
SG177025A1
(en)
|
2010-06-21 |
2012-01-30 |
Agency Science Tech & Res |
Hepatitis b virus specific antibody and uses thereof
|
WO2011106106A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
HUE030720T2
(en)
|
2010-05-31 |
2017-06-28 |
Ono Pharmaceutical Co |
Purinone derivative as btk kinase inhibitor
|
US8907053B2
(en)
|
2010-06-25 |
2014-12-09 |
Aurigene Discovery Technologies Limited |
Immunosuppression modulating compounds
|
KR101209266B1
(ko)
|
2010-06-30 |
2012-12-06 |
한국과학기술연구원 |
생분해성 및 온도 감응성 폴리포스파젠계 자성 고분자, 그의 제조 방법 및 용도
|
BR112013007678A2
(pt)
|
2010-10-01 |
2017-07-04 |
Ventirx Pharmaceuticals Inc |
método para tratamento de doenças alérgicas
|
CN107970451A
(zh)
|
2010-10-01 |
2018-05-01 |
帆德制药股份有限公司 |
Tlr激动剂和联合治疗的治疗应用
|
AR084217A1
(es)
|
2010-12-10 |
2013-05-02 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
US9220779B2
(en)
|
2010-12-30 |
2015-12-29 |
Samyang Biopharmaceuticals Corporation |
Carrier for negatively charged drugs comprising a cationic lipid and a preparation method thereof
|
EP2663550B1
(en)
|
2011-01-12 |
2016-12-14 |
VentiRx Pharmaceuticals, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
PT2663555T
(pt)
|
2011-01-12 |
2017-03-23 |
Array Biopharma Inc |
Benzoazepinas substituídas como moduladores de recetores tipo-toll
|
US9238679B2
(en)
|
2011-02-11 |
2016-01-19 |
The Trustees Of The University Of Pennslyvania |
Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same
|
EA037377B1
(ru)
|
2011-02-11 |
2021-03-22 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Вакцина для индукции иммунного ответа на hbv
|
SG192285A1
(en)
|
2011-02-12 |
2013-09-30 |
Globeimmune Inc |
Yeast-based therapeutic for chronic hepatitis b infection
|
AU2012238564A1
(en)
|
2011-04-08 |
2013-09-26 |
Janssen Sciences Ireland Uc |
Pyrimidine derivatives for the treatment of viral infections
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
EA028254B1
(ru)
|
2011-05-18 |
2017-10-31 |
Янссен Сайенсиз Айрлэнд Юси |
Хиназолиновые производные для лечения вирусных инфекций и дальнейших заболеваний
|
GB201108879D0
(en)
|
2011-05-25 |
2011-07-06 |
Isis Innovation |
Vector
|
US9096642B2
(en)
|
2011-06-08 |
2015-08-04 |
Aurigene Discovery Technologies Limited |
Therapeutic compounds for immunomodulation
|
TWI575070B
(zh)
*
|
2011-07-12 |
2017-03-21 |
傳斯堅公司 |
Hbv聚合酶突變體
|
DE102011080362A1
(de)
|
2011-08-03 |
2013-02-07 |
Robert Bosch Gmbh |
Elektrisches Kontaktelement mit Rastlanze für ein Steckergehäuse
|
AU2012318580A1
(en)
|
2011-10-04 |
2014-05-22 |
Gilead Calistoga Llc |
Novel quinoxaline inhibitors of PI3K
|
KR101383324B1
(ko)
|
2011-11-10 |
2014-04-28 |
주식회사 종근당 |
신규한 유전자 전달용 조성물
|
WO2013078433A1
(en)
|
2011-11-23 |
2013-05-30 |
University Of Hawaii |
Auto-processing domains for polypeptide expression
|
LT2786996T
(lt)
|
2011-11-29 |
2017-01-10 |
Ono Pharmaceutical Co., Ltd. |
Purinono darinio hidrochloridas
|
AU2012350229B2
(en)
*
|
2011-12-09 |
2018-03-22 |
Institut Pasteur |
Multiplex immuno screening assay
|
MX359634B
(es)
|
2011-12-21 |
2018-10-03 |
Novira Therapeutics Inc |
Agentes antivirales contra la hepatitis b.
|
WO2013116562A1
(en)
|
2012-02-03 |
2013-08-08 |
Gilead Calistoga Llc |
Compositions and methods of treating a disease with (s)-4 amino-6-((1-(5-chloro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)ethyl)amino)pyrimidine-5-carbonitrile
|
AU2013218072B2
(en)
|
2012-02-08 |
2017-08-31 |
Janssen Sciences Ireland Uc |
Piperidino-pyrimidine derivatives for the treatment of viral infections
|
WO2013132317A1
(en)
|
2012-03-07 |
2013-09-12 |
Aurigene Discovery Technologies Limited |
Peptidomimetic compounds as immunomodulators
|
RU2014143443A
(ru)
|
2012-03-29 |
2016-05-20 |
Ориджин Дискавери Текнолоджиз Лимитед |
Иммуномодулирующие циклические соединения
|
EP2831060B1
(en)
|
2012-03-31 |
2016-05-04 |
F.Hoffmann-La Roche Ag |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
US20130267517A1
(en)
|
2012-03-31 |
2013-10-10 |
Hoffmann-La Roche Inc. |
Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
AR091279A1
(es)
|
2012-06-08 |
2015-01-21 |
Gilead Sciences Inc |
Inhibidores macrociclicos de virus flaviviridae
|
SG11201408045UA
(en)
|
2012-06-08 |
2015-01-29 |
Gilead Sciences Inc |
MACROCYCLIC INHIBITORS OF <i>FLAVIVIRIDAE</i> VIRUSES
|
ES2624223T3
(es)
|
2012-06-08 |
2017-07-13 |
Gilead Sciences, Inc. |
Inhibidores macrocíclicos de los virus flaviviridae
|
BR122020023349B1
(pt)
|
2012-06-11 |
2023-02-07 |
Xiamen University |
Anticorpo monoclonal, linha de célula de hibridoma, kit e uso do anticorpo monoclonal ou um fragmento de ligação ao antígeno do mesmo
|
KR102216479B1
(ko)
|
2012-08-10 |
2021-02-17 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
바이러스 감염 또는 추가 질환의 치료를 위한 알킬피리미딘 유도체
|
CA2884870C
(en)
|
2012-08-13 |
2022-03-29 |
Massachusetts Institute Of Technology |
Amine-containing lipidoids and uses thereof
|
EP2890683B1
(en)
|
2012-08-28 |
2016-10-12 |
Janssen Sciences Ireland UC |
Fused bicyclic sulfamoyl derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
BR112015004192B1
(pt)
|
2012-08-28 |
2021-02-09 |
Janssen Sciences Ireland Uc |
sulfamoíl-arilamidas, composição farmacêutica que os compreende e uso das mesmas no tratamento da hepatite b
|
WO2014037480A1
(en)
|
2012-09-10 |
2014-03-13 |
F. Hoffmann-La Roche Ag |
6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
PT3023415T
(pt)
|
2012-10-02 |
2018-02-27 |
Gilead Sciences Inc |
Inibidores de desmetilases de histonas
|
PL2906563T3
(pl)
|
2012-10-10 |
2018-10-31 |
Janssen Sciences Ireland Uc |
Pochodne pirolo[3,2-d]pirymidyny do leczenia infekcji wirusowych i innych chorób
|
KR101268466B1
(ko)
|
2012-11-12 |
2013-06-04 |
유병수 |
사축형 윈드 터빈
|
JP6297055B2
(ja)
|
2012-11-16 |
2018-03-20 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
ウイルス感染症の治療のための複素環置換2−アミノ−キナゾリン誘導体
|
MX2015007205A
(es)
|
2012-12-06 |
2016-03-31 |
Quanticel Pharmaceuticals Inc |
Inhibidores de la desmetilasa de histona.
|
JP6256772B2
(ja)
|
2012-12-19 |
2018-01-10 |
セルジーン クオンティセル リサーチ,インク. |
ヒストンデメチラーゼ阻害剤
|
NZ708870A
(en)
|
2012-12-21 |
2016-09-30 |
Gilead Calistoga Llc |
Isoquinolinone or quinazolinone phosphatidylinositol 3-kinase inhibitors
|
EA028774B1
(ru)
|
2012-12-21 |
2017-12-29 |
Квонтисел Фармасьютикалс, Инк. |
Ингибиторы гистондеметилазы
|
AU2013364068B2
(en)
|
2012-12-21 |
2016-10-20 |
Gilead Calistoga Llc |
Substituted pyrimidine aminoalkyl-quinazolones as phosphatidylinositol 3-kinase inhibitors
|
EP2958900B1
(en)
|
2013-02-21 |
2019-04-10 |
Janssen Sciences Ireland Unlimited Company |
2-aminopyrimidine derivatives for the treatment of viral infections
|
PL2961736T3
(pl)
|
2013-02-27 |
2018-08-31 |
Gilead Sciences, Inc. |
Inhibitory demetylaz histonowych
|
JP6466348B2
(ja)
|
2013-02-28 |
2019-02-06 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
スルファモイル−アリールアミドおよびb型肝炎を処置するための医薬品としてのその使用
|
WO2014165128A2
(en)
|
2013-03-12 |
2014-10-09 |
Novira Therapeutics, Inc. |
Hepatitis b antiviral agents
|
WO2014164708A1
(en)
|
2013-03-12 |
2014-10-09 |
Quanticel Pharmaceuticals, Inc. |
Histone dementhylase inhibitors
|
US10035801B2
(en)
|
2013-03-13 |
2018-07-31 |
Genentech, Inc. |
Pyrazolo compounds and uses thereof
|
CN104043120B
(zh)
|
2013-03-13 |
2017-05-31 |
南京赛威信生物医药有限公司 |
乙型肝炎疫苗
|
AU2014236711A1
(en)
|
2013-03-14 |
2015-09-17 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
EP2970394A4
(en)
|
2013-03-14 |
2016-08-10 |
Altravax Inc |
VACCINES AGAINST HEPATITIS B VIRUS
|
US9308236B2
(en)
|
2013-03-15 |
2016-04-12 |
Bristol-Myers Squibb Company |
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
|
HUE034906T2
(hu)
|
2013-03-15 |
2018-03-28 |
Quanticel Pharmaceuticals Inc |
Hiszton-demetiláz inhibitorok
|
DK2981536T3
(en)
|
2013-04-03 |
2017-09-25 |
Janssen Sciences Ireland Uc |
N-PHENYLC CARBOXAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
|
EP2983708A4
(en)
*
|
2013-04-08 |
2016-10-05 |
Medimmune Llc |
VACCINE COMPOSITION AND METHOD OF USE
|
ES2822584T3
(es)
|
2013-05-03 |
2021-05-04 |
Univ California |
Inducción de dinucleótidos cíclicos del interferón tipo I
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
MX2015015692A
(es)
|
2013-05-17 |
2016-03-04 |
Hoffmann La Roche |
Novedosas heteroarildihidropirimidinas, unidas por puentes en 6 para el tratamiento y la profilaxis de infeccion por el virus de hepatitis b.
|
CN105960400B
(zh)
|
2013-05-17 |
2019-05-31 |
爱尔兰詹森科学公司 |
氨磺酰基噻吩酰胺衍生物及其作为药物用于治疗乙型肝炎的用途
|
TR201806822T4
(tr)
|
2013-06-14 |
2018-06-21 |
Gilead Calistoga Llc |
Fosfatidilinositol 3-kinaz inhibitörleri.
|
EP3357906B1
(en)
|
2013-07-25 |
2019-12-04 |
Janssen Sciences Ireland Unlimited Company |
Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
DK3404031T3
(da)
|
2013-07-30 |
2020-12-14 |
Janssen Sciences Ireland Unlimited Co |
Thieno[3,2-d]pyrimidinderivater til behandling af virusinfektioner
|
WO2015019284A2
(en)
|
2013-08-05 |
2015-02-12 |
Cambridge Enterprise Limited |
Inhibition of cxcr4 signaling in cancer immunotherapy
|
US10471139B2
(en)
|
2013-08-15 |
2019-11-12 |
The University Of Kansas |
Toll-like receptor agonists
|
US9872852B2
(en)
|
2013-09-04 |
2018-01-23 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
EP3041468B1
(en)
|
2013-09-06 |
2018-06-13 |
Aurigene Discovery Technologies Limited |
Cyclic peptidomimetic compounds as immunomodulators
|
ES2682040T3
(es)
|
2013-09-06 |
2018-09-18 |
Aurigene Discovery Technologies Limited |
Derivados de 1,3,4-oxadiazol y 1,3,4-tiadiazol como inmunomoduladores
|
AU2014316682B2
(en)
|
2013-09-06 |
2018-11-22 |
Aurigene Discovery Technologies Limited |
1,2,4-oxadiazole derivatives as immunomodulators
|
WO2015036927A1
(en)
|
2013-09-10 |
2015-03-19 |
Aurigene Discovery Technologies Limited |
Immunomodulating peptidomimetic derivatives
|
CA2923090C
(en)
|
2013-09-11 |
2018-08-21 |
Poxel |
Methods and pharmaceutical compositions for the treatment of hepatitis b virus infection
|
WO2015044900A1
(en)
|
2013-09-27 |
2015-04-02 |
Aurigene Discovery Technologies Limited |
Therapeutic immunomodulating compounds
|
ES2670550T3
(es)
|
2013-10-14 |
2018-05-30 |
Eisai R&D Management Co., Ltd. |
Derivados de quinolina selectivamente sustituidos
|
PT3057964T
(pt)
|
2013-10-14 |
2020-02-25 |
Eisai R&D Man Co Ltd |
Compostos de quinolina seletivamente substituídos
|
CA2923712C
(en)
|
2013-10-23 |
2021-11-02 |
Janssen Sciences Ireland Uc |
Carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
US9115113B2
(en)
|
2013-11-14 |
2015-08-25 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
US9643967B2
(en)
|
2013-12-13 |
2017-05-09 |
Takeda Pharmaceutical Company Limited |
Pyrrolo[3,2-c]pyridine derivatives as TLR inhibitors
|
US10654807B2
(en)
|
2013-12-20 |
2020-05-19 |
The University Of Kansas |
Toll-like receptor 8 agonists
|
US9181288B2
(en)
|
2014-01-16 |
2015-11-10 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
US9169212B2
(en)
|
2014-01-16 |
2015-10-27 |
Novira Therapeutics, Inc. |
Azepane derivatives and methods of treating hepatitis B infections
|
CA2931329A1
(en)
|
2014-01-30 |
2015-08-06 |
F. Hoffmann-La Roche Ag |
Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection
|
JP2017508785A
(ja)
|
2014-02-04 |
2017-03-30 |
インサイト・コーポレイションIncyte Corporation |
癌を治療するためのpd−1アンタゴニストおよびido1阻害剤の組み合わせ
|
CA2932551A1
(en)
|
2014-02-06 |
2015-08-13 |
Janssen Sciences Ireland Uc |
Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
|
CN106255510A
(zh)
|
2014-03-05 |
2016-12-21 |
百时美施贵宝公司 |
使用抗pd‑1抗体与另一抗癌剂的组合治疗肾癌
|
SG11201607332UA
(en)
|
2014-03-07 |
2016-10-28 |
Hoffmann La Roche |
Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
|
US9400280B2
(en)
|
2014-03-27 |
2016-07-26 |
Novira Therapeutics, Inc. |
Piperidine derivatives and methods of treating hepatitis B infections
|
US9850225B2
(en)
|
2014-04-14 |
2017-12-26 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
RU2698902C2
(ru)
|
2014-04-22 |
2019-09-02 |
Ф. Хоффманн-Ля Рош Аг |
Производные 4-амино-имидазохинолина, полезные при лечении заболеваний, опосредованных агонистами tlr7 и/или tlr8
|
US9944649B2
(en)
|
2014-05-01 |
2018-04-17 |
Novartis Ag |
Compounds and compositions as toll-like receptor 7 agonists
|
AU2015253215B2
(en)
|
2014-05-01 |
2017-04-13 |
Novartis Ag |
Compounds and compositions as Toll-Like Receptor 7 agonists
|
RU2016146365A
(ru)
|
2014-05-13 |
2018-06-19 |
Ф. Хоффманн-Ля Рош Аг |
Новые дигидрохинолизиноны для лечения и профилактики заражения вирусом гепатита b
|
EP3143144A4
(en)
*
|
2014-05-16 |
2017-12-20 |
Yale University |
VIRUS LIKE VESICLES (VLVs) BASED VACCINES TO PREVENT OR TREAT CHRONIC HEPATITIS B VIRUS (HBV) INFECTION
|
KR102535283B1
(ko)
|
2014-05-23 |
2023-05-22 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
암의 치료를 위한 조합 요법
|
US10342861B2
(en)
|
2014-05-27 |
2019-07-09 |
University Of Rochester |
Arenavirus vaccine
|
CA2951259A1
(en)
|
2014-06-06 |
2015-12-10 |
Flexus Biosciences, Inc. |
Immunoregulatory agents
|
WO2016012470A1
(en)
|
2014-07-25 |
2016-01-28 |
F. Hoffmann-La Roche Ag |
New amorphous and crystalline forms of (3s)-4-[[(4r)-4-(2-chloro-4-fluoro-phenyl)-5-methoxycarbonyl-2-thiazol-2-yl-1, 4-dihydropyrimidin-6-yl]methyl]morpholine-3-carboxylic acid
|
US9943585B2
(en)
|
2014-07-30 |
2018-04-17 |
University Of Rochester |
Methods and compositions related to reorganization of arenavirus genome for development of novel arenavirus live-attenuated vaccines (LAV)
|
EP3174538B1
(en)
|
2014-08-01 |
2019-11-06 |
3M Innovative Properties Company |
Methods and therapeutic combinations for treating tumors
|
WO2016023877A1
(en)
|
2014-08-14 |
2016-02-18 |
F. Hoffmann-La Roche Ag |
Novel pyridazones and triazinones for the treatment and prophylaxis of hepatitis b virus infection
|
CN112898308A
(zh)
|
2014-08-15 |
2021-06-04 |
正大天晴药业集团股份有限公司 |
作为tlr7激动剂的吡咯并嘧啶化合物
|
US20170275287A1
(en)
|
2014-08-22 |
2017-09-28 |
Janus Biotherapeutics, Inc. |
Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
|
BR112017003442A2
(pt)
|
2014-08-27 |
2017-11-28 |
Gilead Sciences Inc |
compostos e métodos para inibir histona desmetilases
|
US9884866B2
(en)
|
2014-09-08 |
2018-02-06 |
Regents Of The University Of Minnesota |
Immunomodulators and immunomodulator conjugates
|
JP6405457B2
(ja)
|
2014-09-11 |
2018-10-17 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
Pd−1/pd−l1およびcd80(b7−1)/pd−l1タンパク質/タンパク質相互作用の大環状阻害剤
|
CN107912040B
(zh)
|
2014-10-10 |
2021-04-06 |
基因泰克公司 |
作为组蛋白脱甲基酶抑制剂的吡咯烷酰胺化合物
|
US9732119B2
(en)
|
2014-10-10 |
2017-08-15 |
Bristol-Myers Squibb Company |
Immunomodulators
|
CN107001386A
(zh)
|
2014-10-11 |
2017-08-01 |
豪夫迈·罗氏有限公司 |
用于治疗感染性疾病的化合物
|
US9637485B2
(en)
|
2014-11-03 |
2017-05-02 |
Hoffmann-La Roche Inc. |
6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection
|
UY36390A
(es)
|
2014-11-05 |
2016-06-01 |
Flexus Biosciences Inc |
Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
|
BR112017009648A2
(pt)
|
2014-11-13 |
2017-12-19 |
Glaxosmithkline Biologicals Sa |
composto, métodos para tratamento de doenças alérgicas ou outras condições inflamatórias ou prevenção de doença, de rinite alérgica ou asma, composição, e, uso de um composto.
|
CA2967720C
(en)
|
2014-11-13 |
2024-01-02 |
Universite De Geneve |
Tri-segmented arenaviruses as vaccine vectors
|
US9856292B2
(en)
|
2014-11-14 |
2018-01-02 |
Bristol-Myers Squibb Company |
Immunomodulators
|
CA2970093A1
(en)
|
2014-12-08 |
2016-06-16 |
Brian Chen |
Cleavable nucleic acid linkers for protein quantification ratioing
|
HUE053704T2
(hu)
|
2014-12-08 |
2021-07-28 |
Hoffmann La Roche |
3-szubsztitutált 5-amino-6H-tiazolo[4,5-d]pirimidin-2,7-dion vegyületek vírusfertõzések kezelésére és megelõzésére
|
US9861680B2
(en)
|
2014-12-18 |
2018-01-09 |
Bristol-Myers Squibb Company |
Immunomodulators
|
WO2016096778A1
(en)
|
2014-12-18 |
2016-06-23 |
F. Hoffmann-La Roche Ag |
Benzazepine sulfonamide compounds
|
US9944678B2
(en)
|
2014-12-19 |
2018-04-17 |
Bristol-Myers Squibb Company |
Immunomodulators
|
AR103222A1
(es)
|
2014-12-23 |
2017-04-26 |
Hoffmann La Roche |
Procedimiento para la preparación de análogos de 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidina
|
US9676793B2
(en)
|
2014-12-23 |
2017-06-13 |
Hoffmann-Laroche Inc. |
Co-crystals of 5-amino-2-oxothiazolo[4,5-d]pyrimidin-3(2H)-yl-5-hydroxymethyl tetrahydrofuran-3-yl acetate and methods for preparing and using the same
|
CN105732635A
(zh)
|
2014-12-29 |
2016-07-06 |
南京明德新药研发股份有限公司 |
一类Toll样受体7激动剂
|
WO2016107832A1
(en)
|
2014-12-30 |
2016-07-07 |
F. Hoffmann-La Roche Ag |
Novel tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis b virus infection
|
AU2015373996B2
(en)
|
2014-12-30 |
2020-10-08 |
Novira Therapeutics, Inc. |
Derivatives and methods of treating hepatitis B infections
|
CN107109497A
(zh)
|
2014-12-31 |
2017-08-29 |
豪夫迈·罗氏有限公司 |
通过实时PCR从细胞裂解物定量HBV cccDNA的高通量新方法
|
MA41338B1
(fr)
|
2015-01-16 |
2019-07-31 |
Hoffmann La Roche |
Composés de pyrazine pour le traitement de maladies infectieuses
|
EP3250685A1
(en)
|
2015-01-27 |
2017-12-06 |
F. Hoffmann-La Roche AG |
Recombinant hbv cccdna, the method to generate thereof and the use thereof
|
CN107207505B
(zh)
|
2015-02-11 |
2018-12-14 |
豪夫迈·罗氏有限公司 |
治疗和预防乙型肝炎病毒感染的 2-氧代-6,7-二氢苯并[a]喹嗪-3-甲酸衍生物
|
EP3256156A1
(en)
*
|
2015-02-13 |
2017-12-20 |
Transgene SA |
Immunotherapeutic vaccine and antibody combination therapy
|
CU20170115A7
(es)
|
2015-03-04 |
2018-03-13 |
Gilead Sciences Inc |
Compuestos moduladores de receptor de tipo toll
|
CA2972148C
(en)
|
2015-03-06 |
2023-08-01 |
F. Hoffmann-La Roche Ag |
Benzazepine dicarboxamide compounds
|
JP2018507885A
(ja)
|
2015-03-10 |
2018-03-22 |
オーリジーン ディスカバリー テクノロジーズ リミテッドAurigene Discovery Technologies Limited |
免疫調節剤としての1,3,4−オキサジアゾールおよびチアジアゾール化合物
|
JP2018507884A
(ja)
|
2015-03-10 |
2018-03-22 |
オーリジーン ディスカバリー テクノロジーズ リミテッドAurigene Discovery Technologies Limited |
免疫調節剤としての3−置換1,3,4−オキサジアゾールおよびチアジアゾール化合物
|
PL3267984T3
(pl)
|
2015-03-10 |
2022-05-02 |
Aurigene Discovery Technologies Limited |
Związki 1,2,4-oksadiazolu i tiadiazolu jako immunomodulatory
|
CA2979142A1
(en)
|
2015-03-10 |
2016-09-15 |
Aurigene Discovery Technologies Limited |
Therapeutic cyclic compounds as immunomodulators
|
CA2979161A1
(en)
|
2015-03-10 |
2016-09-15 |
Aurigene Discovery Technologies Limited |
3-substituted-1,2,4-oxadiazole and thiadiazole compounds as immunomodulators
|
US9809625B2
(en)
|
2015-03-18 |
2017-11-07 |
Bristol-Myers Squibb Company |
Immunomodulators
|
WO2016161268A1
(en)
|
2015-04-01 |
2016-10-06 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antviral agents
|
EP3283472B1
(en)
|
2015-04-17 |
2021-04-14 |
Indiana University Research & Technology Corporation |
Hepatitis b viral assembly effectors
|
EP3292120B1
(en)
|
2015-05-04 |
2019-06-19 |
H. Hoffnabb-La Roche Ag |
Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of hbsag (hbv surface antigen) and hbv dna production for the treatment of hepatitis b virus infections
|
MY189692A
(en)
|
2015-05-07 |
2022-02-26 |
Memorial Sloan Kettering Cancer Center |
Anti-ox40 antibodies and methods of use thereof
|
CN107592864B
(zh)
|
2015-05-12 |
2021-04-16 |
豪夫迈·罗氏有限公司 |
用于治疗和预防病毒感染的新的取代的氨基噻唑并嘧啶二酮
|
KR20180026670A
(ko)
*
|
2015-05-26 |
2018-03-13 |
어드박시스, 인크. |
맞춤형 전달 벡터-기반의 면역 요법 및 이의 용도
|
WO2016195982A2
(en)
|
2015-06-01 |
2016-12-08 |
The Penn State Research Foundation |
Hepatitis b virus capsid assembly
|
US20160376864A1
(en)
|
2015-06-29 |
2016-12-29 |
Cameron International Corporation |
Apparatus and method for distributing fluids to a wellbore
|
WO2017001307A1
(en)
|
2015-06-30 |
2017-01-05 |
F. Hoffmann-La Roche Ag |
Novel substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
|
GB201511477D0
(en)
|
2015-06-30 |
2015-08-12 |
Redx Pharma Plc |
Antiviral compounds
|
US10875876B2
(en)
|
2015-07-02 |
2020-12-29 |
Janssen Sciences Ireland Uc |
Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
|
WO2017007701A1
(en)
|
2015-07-07 |
2017-01-12 |
Merck Sharp & Dohme Corp. |
Antiviral phosphodiamide compounds
|
JP6598974B2
(ja)
|
2015-07-21 |
2019-10-30 |
エフ.ホフマン−ラ ロシュ アーゲー |
B型肝炎ウイルス感染症の治療および予防のための新規な三環式4−ピリドン−3−カルボン酸誘導体
|
GB201513010D0
(en)
|
2015-07-23 |
2015-09-09 |
Glaxosmithkline Biolog Sa |
Novel formulation
|
WO2017016960A1
(en)
|
2015-07-24 |
2017-02-02 |
F. Hoffmann-La Roche Ag |
Process for the preparation of (6s)-6-alkyl-10-alkoxy-9-(substituted alkoxy)-2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid analogues
|
EP3328855B1
(en)
|
2015-07-27 |
2019-05-15 |
H. Hoffnabb-La Roche Ag |
Novel tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis b virus infection
|
EP3328858B1
(en)
|
2015-07-28 |
2019-05-15 |
H. Hoffnabb-La Roche Ag |
Novel 6,7-dihydropyrido[2,1-a]phthalazin-2-ones for the treatment and prophylaxis of hepatitis b virus infection
|
JP2018523652A
(ja)
|
2015-07-29 |
2018-08-23 |
ノバルティス アーゲー |
Pd−1アンタゴニストとegfr阻害剤の組み合わせ物
|
TN2018000048A1
(en)
|
2015-08-10 |
2019-07-08 |
Merck Sharp & Dohme |
Antiviral beta-amino acid ester phosphodiamide compounds
|
CR20180101A
(es)
|
2015-08-13 |
2018-04-12 |
Merck Sharp & Dohme |
Compuestos di-nucleóticos cíclicos como agonistas de sting
|
EP3337481B1
(en)
|
2015-08-21 |
2020-11-11 |
The University of Kansas |
Quinoline-2-amine derivatives as human tlr8-selective agonists for increasing immune response
|
WO2017038909A1
(en)
|
2015-08-28 |
2017-03-09 |
Takeda Pharmaceutical Company Limited |
Heterocyclic compounds
|
MX2018002017A
(es)
|
2015-08-31 |
2018-03-26 |
3M Innovative Properties Co |
Compuestos de anillo de imidazo[4,5-c] sustituido con guanidina.
|
KR20180048743A
(ko)
|
2015-09-04 |
2018-05-10 |
토카겐 인크. |
2a 펩타이드를 포함하는 재조합 벡터
|
MA42818A
(fr)
|
2015-09-15 |
2018-07-25 |
Gilead Sciences Inc |
Modulateurs de récepteurs de type toll pour le traitement du vih
|
TWI730985B
(zh)
|
2015-09-15 |
2021-06-21 |
美商艾森伯利生物科學公司 |
B型肝炎核心蛋白質調節劑
|
JP6856900B2
(ja)
|
2015-09-17 |
2021-04-14 |
国立大学法人富山大学 |
トール様受容体7またはトール様受容体9の活性化阻害剤
|
CN108055842B
(zh)
|
2015-09-17 |
2021-06-29 |
豪夫迈·罗氏有限公司 |
亚磺酰基苯基或磺亚胺酰基苯基苯并氮杂䓬
|
CN108135891B
(zh)
|
2015-10-05 |
2021-07-20 |
富士胶片富山化学株式会社 |
抗乙型肝炎病毒药
|
AU2016334826B2
(en)
|
2015-10-07 |
2020-08-27 |
Sumitomo Pharma Co., Ltd. |
Pyrimidine compound
|
US10745382B2
(en)
|
2015-10-15 |
2020-08-18 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
ES2928164T3
(es)
|
2015-10-19 |
2022-11-15 |
Incyte Corp |
Compuestos heterocíclicos como inmunomoduladores
|
BR112018008339A2
(pt)
|
2015-10-28 |
2018-10-30 |
Aduro Biotech Inc |
composições e métodos para ativar estimulador de sinalização dependente do gene de interferon
|
WO2017079669A1
(en)
|
2015-11-04 |
2017-05-11 |
Incyte Corporation |
Pharmaceutical compositions and methods for indoleamine 2,3-dioxygenase inhibition and indications therefor
|
BR112018009032A8
(pt)
*
|
2015-11-04 |
2019-02-26 |
Hookipa Biotech Ag |
vetor viral de arenavírus infeccioso, composição farmacêutica, composição imunogênica, vacina, método para o tratamento ou a prevenção de infecção pelo vírus da hepatite b em um paciente, uso de um vetor viral, ácido nucleico isolado, vetor viral de arenavírus infeccioso deficiente em replicação e método para sua geração
|
BR112018008880B1
(pt)
|
2015-11-05 |
2023-01-17 |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. |
7-(tiazol-5-il) pirrolopirimidina, seu uso, e composição farmacêutica
|
TWI763641B
(zh)
|
2015-11-19 |
2022-05-11 |
美商英塞特公司 |
作為免疫調節劑之雜環化合物
|
AU2016356780A1
(en)
|
2015-11-19 |
2018-06-28 |
Bristol-Myers Squibb Company |
Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof
|
EP3383914A4
(en)
|
2015-12-02 |
2019-10-30 |
Agenus Inc. |
ANTI-OX40 ANTIBODIES AND METHODS OF USE
|
WO2017096276A1
(en)
|
2015-12-02 |
2017-06-08 |
Agenus Inc. |
Anti-gitr antibodies and methods of use thereof
|
WO2017096189A1
(en)
|
2015-12-02 |
2017-06-08 |
Agenus Inc. |
Anti-gitr antibodies and methods of use thereof
|
KR20180083944A
(ko)
|
2015-12-02 |
2018-07-23 |
아게누스 인코포레이티드 |
항체 및 이의 사용 방법
|
RU2020113165A
(ru)
|
2015-12-03 |
2020-06-09 |
Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед |
Циклические пуриновые динуклеотиды в качестве модуляторов sting
|
AU2016364891A1
(en)
|
2015-12-03 |
2018-06-07 |
Agenus Inc. |
Anti-OX40 antibodies and methods of use thereof
|
WO2017100108A1
(en)
|
2015-12-10 |
2017-06-15 |
Merck Sharp & Dohme Corp. |
Antiviral phosphodiamide prodrugs of tenofovir
|
WO2017106740A1
(en)
|
2015-12-16 |
2017-06-22 |
Aduro Biotech, Inc. |
Methods for identifying inhibitors of "stimulator of interferon gene"-dependent interferon production
|
TW201726623A
(zh)
|
2015-12-17 |
2017-08-01 |
英塞特公司 |
作為免疫調節劑之雜環化合物
|
SG11201804170RA
(en)
|
2015-12-17 |
2018-06-28 |
Merck Patent Gmbh |
Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders
|
MA55194A
(fr)
|
2015-12-22 |
2022-05-04 |
Incyte Corp |
Composés hétérocycliques en tant qu'immunomodulateurs
|
US10905760B2
(en)
|
2016-01-28 |
2021-02-02 |
Svenska Vaccinfabriken Produktion Ab |
Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines containing hepatitis B virus genes
|
MX2018010010A
(es)
|
2016-02-19 |
2018-11-09 |
Novartis Ag |
Compuestos tetraciclicos de piridona como antivirales.
|
DK3429596T3
(da)
|
2016-03-18 |
2022-10-24 |
Immune Sensor Llc |
Cykliske dinukleotide forbindelser og brugs metoder
|
EP3433249B1
(en)
|
2016-03-21 |
2022-11-09 |
Council Of Scientific & Industrial Research |
Blocking toll-like receptor 9 signaling with small molecule antagonist
|
US10358463B2
(en)
|
2016-04-05 |
2019-07-23 |
Bristol-Myers Squibb Company |
Immunomodulators
|
US10533007B2
(en)
|
2016-04-19 |
2020-01-14 |
Innate Tumor Immunity, Inc. |
NLRP3 modulators
|
KR20180134395A
(ko)
|
2016-04-19 |
2018-12-18 |
인네이트 튜머 이뮤니티, 인코포레이티드 |
Nlrp3 조정제
|
WO2017186711A1
(en)
|
2016-04-25 |
2017-11-02 |
Invivogen |
Novel complexes of immunostimulatory compounds, and uses thereof
|
WO2017192961A1
(en)
|
2016-05-06 |
2017-11-09 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
WO2017190669A1
(zh)
|
2016-05-06 |
2017-11-09 |
上海迪诺医药科技有限公司 |
苯并氮杂卓衍生物、其制备方法、药物组合物及应用
|
AU2017266738B2
(en)
|
2016-05-18 |
2023-10-12 |
Hookipa Biotech Gmbh |
Tri-segmented Pichinde viruses as vaccine vectors
|
EP3458455B1
(en)
|
2016-05-20 |
2021-06-16 |
F. Hoffmann-La Roche AG |
Novel pyrazine compounds with oxygen, sulfur and nitrogen linker for the treatment of infectious diseases
|
WO2017202704A1
(en)
|
2016-05-23 |
2017-11-30 |
F. Hoffmann-La Roche Ag |
Benzazepine dicarboxamide compounds with tertiary amide function
|
WO2017202703A1
(en)
|
2016-05-23 |
2017-11-30 |
F. Hoffmann-La Roche Ag |
Benzazepine dicarboxamide compounds with secondary amide function
|
JP6957522B2
(ja)
|
2016-05-26 |
2021-11-02 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
B型肝炎ウイルス疾患の治療および予防のためのキサントン誘導体
|
MA45116A
(fr)
|
2016-05-26 |
2021-06-02 |
Incyte Corp |
Composés hétérocycliques comme immunomodulateurs
|
WO2017211791A1
(en)
|
2016-06-07 |
2017-12-14 |
F. Hoffmann-La Roche Ag |
Combination therapy of an hbsag inhibitor and a tlr7 agonist
|
JP2019521972A
(ja)
|
2016-06-10 |
2019-08-08 |
エナンタ ファーマシューティカルズ インコーポレイテッド |
B型肝炎抗ウイルス剤
|
WO2017216054A1
(en)
|
2016-06-12 |
2017-12-21 |
F. Hoffmann-La Roche Ag |
Dihydropyrimidinyl benzazepine carboxamide compounds
|
WO2017216685A1
(en)
|
2016-06-16 |
2017-12-21 |
Novartis Ag |
Pentacyclic pyridone compounds as antivirals
|
WO2017216686A1
(en)
|
2016-06-16 |
2017-12-21 |
Novartis Ag |
8,9-fused 2-oxo-6,7-dihydropyrido-isoquinoline compounds as antivirals
|
UA125391C2
(uk)
|
2016-06-20 |
2022-03-02 |
Інсайт Корпорейшн |
Гетероциклічні сполуки як імуномодулятори
|
WO2017219931A1
(zh)
|
2016-06-22 |
2017-12-28 |
四川科伦博泰生物医药股份有限公司 |
二氢蝶啶酮类衍生物、其制备方法及其用途
|
GB2549809C
(en)
|
2016-06-23 |
2022-11-30 |
Univ Oxford Innovation Ltd |
Vector
|
US10071079B2
(en)
|
2016-06-29 |
2018-09-11 |
Bristol-Myers Squibb Company |
[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
|
AU2017290755B2
(en)
|
2016-06-29 |
2021-07-01 |
Novira Therapeutics, Inc. |
Diazepinone derivatives and their use in the treatment of hepatitis B infections
|
CN109415367B
(zh)
|
2016-06-29 |
2021-04-16 |
豪夫迈·罗氏有限公司 |
用于治疗和预防乙型肝炎病毒感染的新的二氢吡咯并嘧啶类化合物
|
WO2018001952A1
(en)
|
2016-06-29 |
2018-01-04 |
F. Hoffmann-La Roche Ag |
Novel tetrahydropyridopyrimidines for the treatment and prophylaxis of hbv infection
|
CN109843892B
(zh)
|
2016-06-29 |
2022-01-25 |
诺维拉治疗公司 |
噁二氮杂卓酮衍生物及其在治疗乙型肝炎感染中的用途
|
KR102468272B1
(ko)
|
2016-06-30 |
2022-11-18 |
삼성전자주식회사 |
음향 출력 장치 및 그 제어 방법
|
WO2018002319A1
(en)
|
2016-07-01 |
2018-01-04 |
Janssen Sciences Ireland Uc |
Dihydropyranopyrimidines for the treatment of viral infections
|
JP6301402B2
(ja)
|
2016-07-01 |
2018-03-28 |
日新製鋼株式会社 |
フェライト系ステンレス鋼板およびその製造方法
|
US11098077B2
(en)
|
2016-07-05 |
2021-08-24 |
Chinook Therapeutics, Inc. |
Locked nucleic acid cyclic dinucleotide compounds and uses thereof
|
BR112019000247A2
(pt)
|
2016-07-08 |
2019-04-16 |
Bristol-Myers Squibb Company |
derivados de 1,3-di-hidróxi-fenila úteis como imunomoduladores
|
WO2018011160A1
(en)
|
2016-07-14 |
2018-01-18 |
F. Hoffmann-La Roche Ag |
6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine compounds for the treatment of infectious diseases
|
EP3484886B1
(en)
|
2016-07-14 |
2020-03-04 |
Hoffmann-La Roche AG |
6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine and 6,7-dihydro-4h-triazolo[1,5-a]pyrazine compounds for the treatment of infectious diseases
|
JP7034133B2
(ja)
|
2016-07-14 |
2022-03-11 |
エフ.ホフマン-ラ ロシュ アーゲー |
感染性疾患の処置のためのカルボキシ 6,7-ジヒドロ-4H-ピラゾロ[1,5-a]ピラジン化合物
|
CN109476659B
(zh)
|
2016-07-14 |
2021-07-09 |
豪夫迈·罗氏有限公司 |
用于治疗感染性疾病的新的四氢吡唑并吡啶化合物
|
US20180016260A1
(en)
|
2016-07-14 |
2018-01-18 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
WO2018019297A1
(zh)
|
2016-07-29 |
2018-02-01 |
银杏树药业(苏州)有限公司 |
异喹啉酮类化合物及其制备抗病毒药物的应用
|
JP6991213B2
(ja)
|
2016-07-29 |
2022-01-14 |
グアンジョウ・ルペン・ファーマシューティカル・カンパニー・リミテッド |
Hbv感染の治療のための新規治療薬
|
SG11201900619XA
(en)
|
2016-07-30 |
2019-02-27 |
Bristol Myers Squibb Co |
Dimethoxyphenyl substituted indole compounds as tlr7, tlr8 or tlr9 inhibitors
|
JP2019530732A
(ja)
|
2016-08-03 |
2019-10-24 |
アライジング・インターナショナル・インコーポレイテッドArising International, Inc. |
免疫モジュレータとして有用な対称または半対称化合物
|
WO2018036941A1
(en)
|
2016-08-24 |
2018-03-01 |
F. Hoffmann-La Roche Ag |
Combination therapy of an hbv capsid assembly inhibitor and a nucleos(t)ide analogue
|
JOP20190024A1
(ar)
|
2016-08-26 |
2019-02-19 |
Gilead Sciences Inc |
مركبات بيروليزين بها استبدال واستخداماتها
|
CA3034553A1
(en)
|
2016-08-26 |
2018-03-01 |
3M Innovative Properties Company |
Fused [1,2]imidazo[4,5-c] ring compounds substituted with guanidino groups
|
MA46045A
(fr)
|
2016-08-29 |
2021-04-28 |
Incyte Corp |
Composés hétérocycliques utilisés comme immunomodulateurs
|
US10144706B2
(en)
|
2016-09-01 |
2018-12-04 |
Bristol-Myers Squibb Company |
Compounds useful as immunomodulators
|
CN109923106B
(zh)
|
2016-09-02 |
2022-09-13 |
吉利德科学公司 |
toll样受体调节剂化合物
|
ES2826748T3
(es)
|
2016-09-02 |
2021-05-19 |
Gilead Sciences Inc |
Derivados de 4,6-diamino-pirido[3,2-d]pirimidina como moduladores de receptores de tipo Toll
|
WO2018043747A1
(ja)
|
2016-09-05 |
2018-03-08 |
国立大学法人京都大学 |
抗b型肝炎ウイルス剤
|
ES2893166T3
(es)
|
2016-09-07 |
2022-02-08 |
Glaxosmithkline Biologicals Sa |
Derivados de imidazoquinolina y su uso en terapia
|
TWI670266B
(zh)
|
2016-09-09 |
2019-09-01 |
大陸商浙江海正藥業股份有限公司 |
二氫嘧啶類化合物及其製備方法和用途
|
KR102519535B1
(ko)
|
2016-09-09 |
2023-04-06 |
브리스톨-마이어스 스큅 컴퍼니 |
피리딜 치환된 인돌 화합물
|
MX2019002797A
(es)
|
2016-09-09 |
2019-05-09 |
Novartis Ag |
Compuestos y composiciones como inhibidores de los receptores endosomales tipo peaje.
|
WO2018051254A1
(en)
|
2016-09-14 |
2018-03-22 |
Aurigene Discovery Technologies Limited |
Cyclic substituted-1,2,4-oxadiazole compounds as immunomodulators
|
WO2018051255A1
(en)
|
2016-09-14 |
2018-03-22 |
Aurigene Discovery Technologies Limited |
Cyclic substituted-1,3,4-oxadiazole and thiadiazole compounds as immunomodulators
|
US10537590B2
(en)
|
2016-09-30 |
2020-01-21 |
Boehringer Ingelheim International Gmbh |
Cyclic dinucleotide compounds
|
JOP20190070B1
(ar)
|
2016-10-04 |
2023-09-17 |
Merck Sharp And Dohme Llc |
مركبات بنزو[b] ثيوفين كناهضات محفزة لبروتين جينات الإنترفيرون
|
WO2018065360A1
(de)
|
2016-10-07 |
2018-04-12 |
Biolog Life Science Institute Forschungslabor Und Biochemica-Vertrieb Gmbh |
Benzimidazolhaltige cyclische dinukleotide, verfahren zu deren herstellung und ihre verwendung zur aktivierung von stimulator von interferongenen (sting)-abhängigen signalwegen
|
SG11201903042VA
(en)
|
2016-10-14 |
2019-05-30 |
Precision Biosciences Inc |
Engineered meganucleases specific for recognition sequences in the hepatitis b virus genome
|
MX2019004561A
(es)
|
2016-10-20 |
2019-08-05 |
Aurigene Discovery Tech Ltd |
Inhibidores dobles del supresor de inmunoglobulina del dominio v de la activacion de linfocitos t (vista) y las vias de muerte programada 1 (pd-1).
|
EP3532069A4
(en)
|
2016-10-26 |
2020-05-13 |
Merck Sharp & Dohme Corp. |
ARYL-AMIDE PHOSPHODIAMIDE COMPOUNDS ANTIVIRALS
|
WO2018078149A1
(en)
|
2016-10-31 |
2018-05-03 |
F. Hoffmann-La Roche Ag |
Novel cyclicsulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
|
JP7085545B2
(ja)
|
2016-11-07 |
2022-06-16 |
ブリストル-マイヤーズ スクイブ カンパニー |
免疫修飾因子
|
WO2018089628A1
(en)
|
2016-11-09 |
2018-05-17 |
Agenus Inc. |
Anti-ox40 antibodies, anti-gitr antibodies, and methods of use thereof
|
EP3538513A1
(en)
|
2016-11-11 |
2019-09-18 |
Dynavax Technologies Corporation |
Toll-like receptor antagonist compounds and methods of use
|
US11084818B2
(en)
|
2016-11-11 |
2021-08-10 |
Hepo Pharmaceutical Co., Ltd. |
Nitrogen-containing heterocyclic compound, preparation method, intermediate, pharmaceutical composition and use
|
JOP20170188A1
(ar)
|
2016-11-25 |
2019-01-30 |
Janssen Biotech Inc |
ثنائي النوكليوتيدات الحلقية كمنبهات ستينغ (sting)
|
KR20190084991A
(ko)
|
2016-11-28 |
2019-07-17 |
지앙수 헨그루이 메디슨 컴퍼니 리미티드 |
피라졸로-헤테로아릴 유도체, 이의 제조 방법 및 의학적 용도
|
JOP20170192A1
(ar)
|
2016-12-01 |
2019-01-30 |
Takeda Pharmaceuticals Co |
داي نوكليوتيد حلقي
|
ES2891528T3
(es)
|
2016-12-20 |
2022-01-28 |
Bristol Myers Squibb Co |
Compuestos útiles como inmunomoduladores
|
US20200113924A1
(en)
|
2016-12-20 |
2020-04-16 |
Merck Sharp & Dohme Corp. |
Cyclic dinucleotide sting agonists for cancer treatment
|
AU2017378782A1
(en)
|
2016-12-20 |
2019-07-04 |
Merck Sharp & Dohme Corp. |
Combinations of PD-1 antagonists and cyclic dinucleotide sting agonists for cancer treatment
|
RU2759902C2
(ru)
|
2016-12-22 |
2021-11-18 |
Мерк Шарп И Доум Корп. |
Антивирусные алифатические сложноэфирные пролекарства тенофовира
|
ES2934230T3
(es)
|
2016-12-22 |
2023-02-20 |
Incyte Corp |
Derivados de benzooxazol como inmunomoduladores
|
US20180179179A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
WO2018119236A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Triazolo[1,5-a]pyridine derivatives as immunomodulators
|
WO2018118826A1
(en)
|
2016-12-22 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Antiviral benzyl-amine phosphodiamide compounds
|
EP3558963B1
(en)
|
2016-12-22 |
2022-03-23 |
Incyte Corporation |
Bicyclic heteroaromatic compounds as immunomodulators
|
US20180177784A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds as immunomodulators
|
GB201705765D0
(en)
*
|
2017-04-10 |
2017-05-24 |
Univ Oxford Innovation Ltd |
HBV vaccine
|
JOP20180040A1
(ar)
|
2017-04-20 |
2019-01-30 |
Gilead Sciences Inc |
مثبطات pd-1/pd-l1
|
KR20200066349A
(ko)
|
2017-10-16 |
2020-06-09 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
복제 가능 아데노바이러스 벡터
|
JP2021500880A
(ja)
|
2017-10-16 |
2021-01-14 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
2つの発現カセットを有するサルアデノウイルスベクター
|
GB201721068D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Biologicals Sa |
Hepatitis B immunisation regimen and compositions
|
GB201721069D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Biologicals Sa |
Hepatitis B Immunisation regimen and compositions
|
EA202091513A1
(ru)
*
|
2017-12-19 |
2020-09-09 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Вакцины против вируса гепатита b (hbv) и их применение
|
EA202091516A1
(ru)
|
2017-12-19 |
2020-11-03 |
Янссен Сайенсиз Айрлэнд Анлимитед Компани |
Способы и композиции для индукции иммунного ответа против вируса гепатита b (hbv)
|
EP4137578A1
(en)
|
2018-01-05 |
2023-02-22 |
Ottawa Hospital Research Institute |
Modified vaccinia vectors
|
CR20200347A
(es)
|
2018-02-13 |
2020-09-23 |
Gilead Sciences Inc |
Inhibidores pd-1/pd-l1
|
US11142750B2
(en)
|
2018-04-12 |
2021-10-12 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
|
AU2019301811B2
(en)
|
2018-07-13 |
2022-05-26 |
Gilead Sciences, Inc. |
PD-1/PD-L1 inhibitors
|
EP3986455A1
(en)
|
2019-06-18 |
2022-04-27 |
Janssen Sciences Ireland Unlimited Company |
Arenavirus vectors for hepatitis b virus (hbv) vaccines and uses thereof
|
EP4021923A1
(en)
|
2019-08-29 |
2022-07-06 |
VIR Biotechnology, Inc. |
Hepatitis b virus vaccines
|
US11497808B2
(en)
|
2019-09-30 |
2022-11-15 |
Gilead Sciences, Inc. |
HBV vaccines and methods treating HBV
|